-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
US opioid crisis victims testify at emotional Purdue Pharma hearing
Dozens of victims of the US opioid crisis expressed their grief and anger as they testified on Tuesday against Purdue Pharma, the maker of the pain pill OxyContin which was ordered to pay billions by a judge ahead of its dissolution.
Between 1999 and 2023, around 806,000 people died from opioid overdoses in the United States, according to government data.
Purdue and other opioid makers and distributors are accused of aggressively marketing prescription painkillers like OxyContin starting in the 1990s, while hiding how addictive the drugs are.
Among the victims of the opioid epidemic was the mother of a teenage boy. "Because my mom died, I had depression and thoughts of killing myself," the son told the court in an emotional testimony via video call, sitting next to his father.
"I hope you feel guilty," he told the Sackler family, which owned Purdue for decades.
The family and company are due to pay more than $8 billion in fines, forfeitures and penalties.
The hearing to conclude a Department of Justice probe was originally scheduled to take place remotely, but US Judge Madeline Cox Arleo moved it to an in-person hearing after seeing protesters outside her courthouse in Newark, New Jersey.
"That's the least I could do," the judge told a victim who thanked her.
On Tuesday, some 40 victims and their families attended the hearing, with more joining online. Their testimonies, which Arleo described as "heartbreaking," ran for more than six hours.
- 'Hole in our family' -
Alexis Pleus's son was prescribed OxyContin after suffering a high school football injury.
He died in 2014 from a heroin overdose, leaving a "gaping hole in our family for eternity," said Pleus.
Those who survived addiction spoke of their "guilt" of being alive, while families of those who died blamed themselves for not having done enough.
Many painted a picture of "destroyed" lives: divorces, losing custody of their children, prison, psychiatric hospitals, and astronomical medical bills in the hope of regaining "a normal, meaningful life."
The wives of two men who died recalled losing their homes. One of them said she suffered from post-traumatic stress disorder.
In many cases, families that were torn apart said the nightmare "started in the doctor's offices."
Purdue has admitted to promoting OxyContin by paying doctors to prescribe it, bringing in tens of billions of dollars for the laboratory and the Sackler family.
For many, opioid addiction begins with prescribed painkillers before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Many in the courtroom wept during the hearing, and the judge was visibly emotional when listening to Julie Werner Strickler, whose son was prescribed his first pills in the army.
"These people are not statistics in an epidemiological study," the judge said when handing down the sentence.
- 'Criminal enterprise' -
After Arleo read the names of more than 200 victims who had submitted written statements, she ordered Steve Miller, Purdue Pharma's board chair, to apologize to them.
Arleo also apologized on behalf of the US government, saying it had "failed" to protect the public from Purdue, which she likened to a "criminal enterprise."
The sentence against Purdue paves the way for bankruptcy proceedings and its dissolution on May 1, as agreed in a settlement with several US states last year.
What remains of Purdue will be replaced by Knoa Pharma, a public benefit company that will provide opioid-use disorder treatments and overdose reversal medicines.
Several victims on Tuesday called for the rejection of the settlement, which would protect the Sackler family from criminal prosecution.
Expressing her frustration with the deal, Arleo said that it was still the "best route."
"It's no shock. This is the second time I've been in a courtroom where the judge was apologetic and basically said there should have been jail sentences included. But there's always a 'but,'" said Edward Bisch, who lost his teenage son in the epidemic.
For many victims and their families, the fight continues daily in community initiatives to prevent and treat opioid addiction, which are set to receive part of the sums owed by Purdue.
R.Chavez--AT